Altered relationship between body fat and plasma adiponectin in end-stage renal disease

Metabolism: Clinical and Experimental

Volumn 54, Issue 3, 2005, Pages 330-334

  Shoji, Tetsuo ^a   Shinohara, Kayo ^a   Hatsuda, Sawako ^a   Kimoto, Eiji ^a   Fukumoto, Shinya ^a   Emoto, Masanori ^a   Tahara, Hideki ^a   Koyama, Hidenori ^a   Ishimura, Eiji ^a   Miki, Takami ^a   Tabata, Tsutomu ^b   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

EID: 13844266009     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.09.012     Document Type: Article

References (28)

1. T. Kawagishi, Y. Nishizawa, and T. Konishi High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia Kidney Int. 48 1995 820 826
2. T. Shoji, Y. Nishizawa, and T. Kawagishi Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients J. Am. Soc. Nephrol. 9 1998 1277 1284
3. T. Shoji, T. Kawagishi, and M. Emoto Additive impacts of diabetes and renal failure on carotid atherosclerosis Atherosclerosis 153 2000 257 258
4. T. Shoji, M. Emoto, and K. Shinohara Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease J. Am. Soc. Nephrol. 12 2001 2117 2124
5. A. Lindner, B. Charra, and D.J. Sherrard Accelerated atherosclerosis in prolonged maintenance hemodialysis N. Engl. J. Med. 290 1974 697 701
6. P. Degoulet, M. Legrain, and I. Reach Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study Nephron 31 1982 103 110
7. S.F. Leavey, R.L. Strawderman, and C.A. Jones Simple nutritional indicators as independent predictors of mortality in hemodialysis patients Am. J. Kidney Dis. 31 1998 997 1006
8. K. Kalantar-Zadeh, G. Block, and M.H. Humphreys Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int. 63 2003 793 808
9. P. Stenvinkel, O. Heimburger, and B. Lindholm Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome) Nephrol. Dial. Transplant. 15 2000 953 960
10. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
11. I. Shimomura, T. Funahashi, and M. Takahashi Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat. Med. 2 1996 800 803
12. Y. Zhang, R. Proenca, and M. Maffei Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
13. K. Maeda, K. Okubo, and I. Shimomura cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem. Biophys. Res. Commun. 221 1996 286 289
14. N. Ouchi, S. Kihara, and Y. Arita Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
15. Y. Matsuzawa, T. Funahashi, and T. Nakamura Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances Ann. N. Y. Acad. Sci. 892 1999 146 154
16. N. Ouchi, S. Kihara, and Y. Arita Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
17. K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler. Thromb. Vasc. Biol. 20 2000 1595 1599
18. K. Hotta, T. Funahashi, and N.L. Bodkin Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133
19. C. Weyer, T. Funahashi, and S. Tanaka Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J. Clin. Endocrinol. Metab. 86 2001 1930 1935
20. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem. Biophys. Res. Commun. 257 1999 79 83
21. W.S. Yang, W.J. Lee, and T. Funahashi Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin J. Clin. Endocrinol. Metab. 86 2001 3815 3819
22. C. Zoccali, F. Mallamaci, and G. Tripepi Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J. Am. Soc. Nephrol. 13 2002 134 141
23. T. Shoji, E. Kimoto, and K. Shinohara Molecular forms of adiponectin in uraemic plasma Nephrol. Dial. Transplant. 19 2004 1937 1938
24. Y. Nishizawa, T. Shoji, and S. Tanaka Plasma leptin level and its relationship with body composition in hemodialysis patients Am. J. Kidney Dis. 31 1998 655 661
25. T. Shoji, Y. Nishizawa, and M. Emoto Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM Diabetologia 40 1997 676 679
26. J.W. Huang, C.J. Yen, and H.W. Chiang Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function Am. J. Kidney Dis. 43 2004 1047 1055
27. H. Nishizawa, I. Shimomura, and K. Kishida Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein Diabetes 51 2002 2734 2741
28. I. Sasagawa, M. Adachi, and T. Sawamura Serum levels of total and free testosterone in men undergoing hemodialysis Arch. Androl. 40 1998 153 158